Research Interests
MycologyAPrf Sarah Kidd
School of Biological Sciences
College of Science
Sarah Kidd is Head of the National Mycology Reference Centre at SA Pathology, Adelaide, and adjunct Associate Professor at the University of Adelaide. She completed a Bachelor of Medical Science with Honours, and a PhD in Medicine, both at the University of Sydney. She holds Fellowships of the Australian Society for Microbiology, and of the European Confederation of Medical Mycology. Research interests include the epidemiology, phylogeny, and antifungal susceptibilities of fungal pathogens.Please note correct email address: SARAH.KIDD@SA.GOV.AU
| Date | Position | Institution name |
|---|---|---|
| 2024 - ongoing | Adjunct Associate Professor | University of Adelaide |
| 2014 - 2024 | Adjunct Senior Lecturer | University of Adelaide |
| 2011 - ongoing | Head, National Mycology Reference Centre | SA Pathology |
| 2011 - 2014 | Adjunct Lecturer | University of Adelaide |
| 2006 - 2010 | Postdoctoral Research Scientist | Monash University, Melbourne |
| 2003 - 2006 | Postdoctoral Research Scientist | University of British Columbia |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2023 | Fellowship | Fellow of the European Confederation of Medical Mycology | ECMM | Australia | - |
| 2023 | Award | Howard Morris Quality Use of Pathology Award | SA Pathology | Australia | - |
| 2018 | Fellowship | Fellowship of the Australian Society for Microbiology | Australian Society for Microbiology | Australia | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2000 - 2003 | University of Sydney | Australia | PhD |
| 1996 - 1999 | University of Sydney | Australia | Bachelor of Medical Science (Hons.) |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2006 - 2010 | Research Fellow | Monash University, Alfred Hospital | Australia |
| 2003 - 2006 | Postdoctoral Research Fellow | University of British Columbia | Canada |
| Year | Citation |
|---|---|
| 2026 | Zhang, S. X., de Hoog, S., Denning, D. W., Ahmed, S. A., Alastruey-Izquierdo, A., Arendrup, M. C., . . . Walsh, T. J. (2026). Reaffirming the importance of nomenclature stability for Candida auris and its associated disease of candidiasis. Journal of Clinical Microbiology, 64(2), 5 pages. Scopus4 WoS2 Europe PMC1 |
| 2026 | Montgomery, S. T., Rezaee, H., Sbaraini, N., Iszatt, J., Mantjani, L., Kidd, S. E., . . . Garratt, L. W. (2026). Draft genome sequences of the pathogenic fungi Scedosporium aurantiacum and Scedosporium apiospermum from clinical isolates. Microbiology Resource Announcements, 15(1), e00896-25-1-e00896-25-3. |
| 2026 | Phillips, K., Acker, K. P., Han, J. -Y., Salvatore, C. M., Permar, S. R., Rolón, R. M., . . . Dubois, M. M. (2026). <i>Trichosporon inkin</i> meningitis in a pediatric patient diagnosed via metagenomic sequencing.. ASM case reports, 1(2), e00053-e00025. |
| 2026 | Neoh, C. F., Chen, S. C. A., Morris, A. J., Heath, C. H., Tan, S. J., Lane, R., . . . Slavin, M. A. (2026). Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand. CLINICAL INFECTIOUS DISEASES, 11 pages. |
| 2026 | Stewart, A. G., Douglas, A. P., Kidd, S. E., Salmanton-García, J., Cornely, O. A., Morris, A. J., . . . Chen, S. C. A. (2026). Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing. Pathology, 58(3), 341-346. |
| 2026 | G O'Donnell, T., MacPhail, A., Blaser, M., Seenarain, A., Kidd, S. E., Halliday, C. L., . . . Tran, T. (2026). Lomentospora prolificans osteomyelitis and septic arthritis in an immunocompromised patient, requiring transhumeral amputation and use of the novel antifungal olorofim. Jses Reviews Reports and Techniques, 6(2), 100698. |
| 2025 | Kidd, S. E., Sandoval-Denis, M., Malik, R., Hagen, F., & Rodrigues, A. M. (2025). Sporothrix davidellisii : A new pathogenic species belonging to the Sporothrix pallida complex. Medical Mycology, 63(4), 14 pages. Scopus5 WoS5 Europe PMC3 |
| 2025 | Tong, L. J., Thng, J., Lester, N., Caporn, T., Gardam, D., Kocic, D., . . . Malik, R. (2025). Disseminated Penicillium labradoris (synonym: P. labradorum) in three dogs from Western Australia. Australian Veterinary Journal, 103(10), 642-654. Scopus1 |
| 2024 | Birnie, J. D., Ahmed, T., Kidd, S. E., Westall, G. P., Snell, G. I., Peleg, A. Y., & Morrissey, C. O. (2024). Multi-Locus Microsatellite Typing of Colonising and Invasive Aspergillus fumigatus Isolates from Patients Post Lung Transplantation and with Chronic Lung Disease. Journal of Fungi, 10(2), 19 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Kidd, S. E., Hagen, F., Halliday, C. L., Abdolrasouli, A., Boekhout, T., Crous, P. W., . . . Chen, S. C. -A. (2024). Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion. Journal of Clinical Microbiology, 62(4), e01570-23-1-e01570-23-3. Scopus2 WoS2 Europe PMC2 |
| 2024 | Neoh, C. F., Chen, S. C. A., Lanternier, F., Tio, S. Y., Halliday, C. L., Kidd, S. E., . . . Slavin, M. A. (2024). Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections. Clinical Microbiology Reviews, 37(2), 75 pages. Scopus33 WoS33 Europe PMC23 |
| 2024 | Skinner, C., Allavena, R., Hoffmann, K., Kelly-Bosma, M., Kidd, S., & Thomson, C. (2024). Disseminated Rasamsonia argillacea complex infection presenting as intraventricular brain hemorrhage in a German shepherd dog in Australia. Medical Mycology Case Reports, 44, 100641. Scopus1 |
| 2024 | Kim, L. N., Karthik, H., Proudmore, K. E., Kidd, S. E., & Baird, R. W. (2024). Fungal Keratitis, Epidemiology and Outcomes in a Tropical Australian Setting. Tropical Medicine and Infectious Disease, 9(6), 9 pages. Scopus5 WoS3 Europe PMC1 |
| 2024 | Beardsley, J., Kim, H. Y., Dao, A., Kidd, S., Alastruey-Izquierdo, A., Sorrell, T. C., . . . Alffenaar, J. W. (2024). Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology, 62(6), 30 pages. Scopus30 WoS28 Europe PMC21 |
| 2024 | Keighley, C., Kim, H. Y., Kidd, S., Chen, S. C. A., Alastruey, A., Dao, A., . . . Alffenaar, J. W. (2024). Candida tropicalis-A systematic review to inform the World Health Organization of a fungal priority pathogens list. Medical Mycology, 62(6), 16 pages. Scopus31 WoS31 Europe PMC24 |
| 2024 | Kim, H. Y., Nguyen, T. A., Kidd, S., Chambers, J., Alastruey-Izquierdo, A., Shin, J. H., . . . Alffenaar, J. W. (2024). Candida auris-a systematic review to inform the world health organization fungal priority pathogens list. Medical Mycology, 62(6), 24 pages. Scopus50 WoS50 Europe PMC39 |
| 2024 | Nguyen, T. A., Kim, H. Y., Stocker, S., Kidd, S., Alastruey-Izquierdo, A., Dao, A., . . . Alffenaar, J. W. (2024). Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens. Medical Mycology, 62(6), 18 pages. Scopus32 WoS27 Europe PMC18 |
| 2024 | Asogan, M., Kim, H. Y., Kidd, S., Alastruey-Izquierdo, A., Govender, N. P., Dao, A., . . . Beardsley, J. (2024). Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list. Medical Mycology, 62(6), 37 pages. Scopus33 WoS32 Europe PMC24 |
| 2024 | Dao, A., Kim, H. Y., Garnham, K., Kidd, S., Sati, H., Perfect, J., . . . Beardsley, J. (2024). Cryptococcosis-a systematic review to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology, 62(6), 24 pages. Scopus35 WoS35 Europe PMC25 |
| 2024 | Crawford, L. C., & Kidd, S. E. (2024). Photo Quiz: Subungual organism in a renal transplant patient. Journal of Clinical Microbiology, 62(8), 4 pages. |
| 2024 | Morris, A. J., Kidd, S. E., Halliday, C. L., Chen, S. C. A., McKinney, W., Ryan, K., & Elvy, J. (2024). Update on methods used for mycological testing: wide diversity and opportunities for improvement persist. Pathology, 56(7), 1021-1027. Scopus3 WoS2 Europe PMC1 |
| 2024 | van Rhijn, N., Arikan-Akdagli, S., Beardsley, J., Bongomin, F., Chakrabarti, A., Chen, S. C. A., . . . Hagen, F. (2024). Beyond bacteria: the growing threat of antifungal resistance. Lancet, 404(10457), 1017-1018. Scopus36 WoS38 Europe PMC33 |
| 2024 | Tio, S. Y., Chen, S. C. A., Heath, C. H., Pradhan, A., Morris, A. J., Korman, T. M., . . . Slavin, M. A. (2024). Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions. Open Forum Infectious Diseases, 11(11), 6 pages. Scopus5 WoS4 Europe PMC4 |
| 2024 | de Hoog, S., Walsh, T. J., Ahmed, S. A., Alastruey-Izquierdo, A., Arendrup, M. C., Borman, A., . . . Zhang, S. X. (2024). Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology. Journal of Clinical Microbiology, 62(12), 19 pages. Scopus11 WoS12 Europe PMC6 |
| 2024 | Kidd, S. E., & Westblade, L. F. (2024). Bipolaris or Curvularia? Resolving the spicy issue of how clinical isolates should be reported. Plos Pathogens, 20(11), 4 pages. |
| 2023 | Tio, S. Y., Chen, S. C. A., Hamilton, K., Heath, C. H., Pradhan, A., Morris, A. J., . . . Slavin, M. A. (2023). Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020. Lancet Regional Health Western Pacific, 40, 14 pages. Scopus18 WoS19 |
| 2023 | Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023). An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Review of Molecular Diagnostics, 23(12), 1135-1152. Scopus43 WoS40 Europe PMC35 |
| 2023 | Kidd, S. E., Abdolrasouli, A., & Hagen, F. (2023). Fungal Nomenclature: Managing Change is the Name of the Game. Open Forum Infectious Diseases, 10(1), ofac559-1-ofac559-15. WoS117 Europe PMC96 |
| 2023 | Kidd, S., Abdolrasouli, A., & Hagen, F. (2023). Reply to “Fungal Nomenclature: Managing Change is the Name of the Game - what about ‘candidiasis’ and ‘fusariosis'”. Open Forum Infectious Diseases, 10(8), 1. Scopus1 WoS1 Europe PMC2 |
| 2023 | O’hern, J. A., Koenen, A., Janson, S., Hajkowicz, K. M., Robertson, I. K., Kidd, S. E., . . . Ralph, A. P. (2023). Epidemiology, management and outcomes of Cryptococcus gattii infections: A 22-year cohort. PLoS Neglected Tropical Diseases, 17(3), e0011162-1-e0011162-20. Scopus6 Europe PMC4 |
| 2022 | Lamont-Friedrich, S. J., Kidd, S. E., Giles, C., Griesser, H. J., & Coad, B. R. (2022). Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin. Medical Mycology, 60(1), 4 pages. Scopus2 WoS2 Europe PMC2 |
| 2022 | Kidd, S. E., Halliday, C. L., Haremza, E., Gardam, D. J., Chen, S. C. A., & Elvy, J. A. (2022). Attitudes of Australasian Clinicians and Laboratory Staff to Changing Fungal Nomenclature: Has Mycological Correctness Really Gone Mad?. Microbiology Spectrum, 10(1), e02377-21-1-e02377-21-6. Scopus8 WoS10 Europe PMC8 |
| 2022 | Kidd, S. E., & Weldhagen, G. F. (2022). Diagnosis of dermatophytes: from microscopy to direct PCR. Microbiology Australia, 43(1), 9-13. Scopus16 WoS17 |
| 2022 | Crawford, L. C., Kidd, S. E., Anninos, T. M., Turra, M., & Weldhagen, G. F. (2022). Candida auris PCR for high-throughput infection control screening. Medical Mycology, 60(8), 6 pages. Scopus8 WoS9 Europe PMC5 |
| 2022 | Halliday, C. L., Weeks, K., Farac, K., Alexiou, H., Green, W., Lopez, R., . . . Kidd, S. E. (2022). Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories. Pathology, 54(7), 922-927. Scopus4 WoS3 Europe PMC2 |
| 2021 | Kay, A., Boland, L., Kidd, S. E., Beatty, J. A., Talbot, J. J., & Barrs, V. R. (2021). Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic Aspergillus species in section Fumigati. Medical Mycology Case Reports, 34, 13-17. Scopus11 WoS6 Europe PMC7 |
| 2021 | Teo, T. S. P., Crawford, L. C., Pilch, W. T., Carney, B., Solanki, N., Kidd, S. E., & Warner, M. S. (2021). Mycetoma caused by Microsporum canis in a patient with renal transplant: A case report and review of the literature. Transplant Infectious Disease, 23(3), 6 pages. Scopus4 WoS19 Europe PMC2 |
| 2021 | Kidd, S. E., Halliday, C. L., McMullan, B., Chen, S. C. -A., & Elvy, J. (2021). New Names for Fungi of Medical Importance: can we Have Our Cake and Eat It Too?. Journal of Clinical Microbiology, 59(3), e02730-20-1-e02730-20-2. Scopus24 WoS21 Europe PMC20 |
| 2021 | Keighley, C. L., Pope, A., Marriott, D. J. E., Chapman, B., Bak, N., Daveson, K., . . . Chen, S. C. A. (2021). Risk factors for candidaemia: A prospective multi-centre case-control study. Mycoses, 64(3), 257-263. Scopus37 WoS34 Europe PMC26 |
| 2021 | Kidd, S. E., Crawford, L. C., & Halliday, C. L. (2021). Antifungal Susceptibility Testing and Identification. Infectious Disease Clinics of North America, 35(2), 313-339. Scopus18 WoS17 Europe PMC17 |
| 2021 | Khanina, A., Tio, S. Y., Ananda-Rajah, M. R., Kidd, S. E., Williams, E., Chee, L., . . . Thursky, K. A. (2021). Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021. Internal Medicine Journal, 51(S7), 18-36. Scopus38 WoS40 Europe PMC32 |
| 2020 | Kidd, S. E., Chen, S. C. A., Meyer, W., & Halliday, C. L. (2020). A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?. Frontiers in Microbiology, 10, 2903-1-2903-20. Scopus152 WoS128 Europe PMC105 |
| 2020 | Ross, I. L., Weldhagen, G. F., & Kidd, S. E. (2020). Detection and identification of dermatophyte fungi in clinical samples using a commercial multiplex tandem PCR assay. Pathology, 52(4), 473-477. Scopus25 WoS21 Europe PMC14 |
| 2020 | Davidson, N., Campbell, K., Foroughi, F., Tayal, V., Lynar, S., Crawford, L. C., . . . Meumann, E. M. (2020). Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature. BMC Infectious Diseases, 20(1), 755-1-755-5. |
| 2019 | Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Botterel, F., Canton, E., Castro, C., . . . Tejada, M. (2019). Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods. Antimicrobial Agents and Chemotherapy, 63(1), 15 pages. Scopus67 WoS59 Europe PMC53 |
| 2019 | Marshall, A. C., Kidd, S. E., Lamont-Friedrich, S. J., Arentz, G., Hoffmann, P., Coad, B. R., & Bruning, J. B. (2019). Structure, mechanism, and inhibition of aspergillus fumigatus thioredoxin reductase. Antimicrobial Agents and Chemotherapy, 63(3), 1-15. Scopus37 WoS36 Europe PMC28 |
| 2019 | Thomson, J., Trott, D. J., Malik, R., Galgut, B., McAllister, M. M., Nimmo, J., . . . Kidd, S. E. (2019). An atypical cause of sporotrichosis in a cat. Medical Mycology Case Reports, 23, 72-76. Scopus27 WoS24 Europe PMC19 |
| 2019 | Keighley, C., Chen, S. C. A., Marriott, D., Pope, A., Chapman, B., Kennedy, K., . . . Slavin, M. A. (2019). Candidaemia and a risk predictive model for overall mortality: A prospective multicentre study. BMC Infectious Diseases, 19(1), 445-1-445-10. Scopus46 WoS41 Europe PMC37 |
| 2019 | Hossain, M. A., Biva, I. J., Kidd, S. E., Whittle, J. D., Griesser, H. J., & Coad, B. R. (2019). Antifungal activity in compounds from the Australian desert plant Eremophila alternifolia with potency against Cryptococcus spp. Antibiotics, 8(2), 34-1-34-12. Scopus12 WoS12 Europe PMC7 |
| 2019 | Chew, S. M., Sweeney, N., Kidd, S. E., & Reed, C. (2019). Candida auris arriving on our shores: an Australian microbiology laboratory's experience. Pathology, 51(4), 431-433. Scopus8 WoS6 Europe PMC5 |
| 2019 | New, D., Beukers, A. G., Kidd, S. E., Merritt, A. J., Weeks, K., Van Hal, S. J., & Arthur, I. (2019). Identification of multiple species and subpopulations among Australian clinical Sporothrix isolates using whole genome sequencing. Medical Mycology, 57(7), 905-908. Scopus22 WoS20 Europe PMC16 |
| 2019 | Meyer, W., Arthur, I., Ellis, D., Kan, A., Kidd, S., Maszewska, K., & Weeks, K. (2019). Australian medical mycology culture collections: Fundamental resources for mycological diagnosis and research. Microbiology Australia, 40(3), 130-134. |
| 2019 | Ong, C. W., Chen, S. C. A., Clark, J. E., Halliday, C. L., Kidd, S. E., Marriott, D. J., . . . Heath, C. H. (2019). Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Internal Medicine Journal, 49(10), 1229-1243. Scopus61 WoS48 Europe PMC43 |
| 2019 | Biswas, C., Marcelino, V., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. (2019). Corrigendum: Whole genome sequencing of australian candida glabrata isolates reveals genetic diversity and novel sequence types (Front. Microbiol., (2018), 9, (2946), 10.3389/fmicb.2018.02946). Frontiers in Microbiology, 10(SEP), 2218. |
| 2019 | Talbot, J. J., Frisvad, J. C., Meis, J. F., Hagen, F., Verweij, P. E., Hibbs, D. E., . . . Houbraken, J. (2019). Cyp51A mutations, extrolite profiles, and antifungal susceptibility in clinical and environmental isolates of the aspergillus viridinutans species complex. Antimicrobial Agents and Chemotherapy, 63(11), 13 pages. Scopus23 WoS21 Europe PMC20 |
| 2019 | Pérez-Hansen, A., Lass-Flörl, C., Lackner, M., Aigner, M., Alastruey-Izquierdo, A., Arikan-Akdagli, S., . . . Willinger, B. (2019). Antifungal susceptibility profiles of rare ascomycetous yeasts. Journal of Antimicrobial Chemotherapy, 74(9), 2649-2656. Scopus33 WoS31 Europe PMC30 |
| 2018 | Bennett, P. F., Talbot, J. J., Martin, P., Kidd, S. E., Makara, M., & Barrs, V. R. (2018). Long term survival of a dog with disseminated Aspergillus deflectus infection without definitive treatment. Medical Mycology Case Reports, 22, 1-3. Scopus10 WoS11 Europe PMC9 |
| 2018 | Marinelli, T., Kidd, S., Shaw, D., & Rowe, E. (2018). Aspergillus fumigatus endocarditis in an indigenous Australian male without classic risk factors. Medical Mycology Case Reports, 22, 61-64. Scopus5 WoS4 Europe PMC5 |
| 2018 | Kidd, S. E., Halliday, C. L., Morris, A. J., & Chen, S. C. A. (2018). Antifungal susceptibility testing in Australasian clinical laboratories: we must improve our performance. Pathology, 50(3), 257-260. Scopus6 WoS6 Europe PMC6 |
| 2018 | Espinel-Ingroff, A., Turnidge, J., Alastruey-Izquierdo, A., Dannaoui, E., Garcia-Effron, G., Guinea, J., . . . Tortorano, A. M. (2018). Posaconazole MIC distributions for aspergillus fumigatus species complex by four methods: Impact of cyp51a mutations on estimation of epidemiological cutoff values. Antimicrobial Agents and Chemotherapy, 62(4), 11 pages. Scopus42 WoS39 Europe PMC35 |
| 2018 | Biswas, C., Marcelino, V. R., Van Hal, S., Halliday, C., Martinez, E., Wang, Q., . . . Chen, S. C. A. (2018). Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types. Frontiers in Microbiology, 9, 12 pages. Scopus43 WoS44 Europe PMC46 |
| 2017 | Talbott, J. J., Houbraken, J., Frisvad, J. C., Samson, R. A., Kidd, S., Pitt, J., . . . Barrs, V. R. (2017). Discovery of Aspergillus frankstonensis sp. nov. during environmental sampling for animal and human fungal pathogens. PLoS ONE, 12(8), e0181660-1-e0181660-17. Scopus15 WoS12 Europe PMC11 |
| 2017 | Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, R., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). Multicenter, International Study of MIC/ MEC Distributions for definition of epidemiological cutoff values for sporothrix species identified by molecular methods. Antimicrobial Agents and Chemotherapy, 61(10), e01057-17-1-e01057-17-8. Scopus107 WoS91 Europe PMC83 |
| 2017 | Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Changing epidemiology of candidaemia in Australia.. The Journal of antimicrobial chemotherapy, 72(4), 1103-1108. Scopus147 WoS122 Europe PMC87 |
| 2017 | Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., . . . Chen, S. (2017). Erratum: Changing epidemiology of candidaemia in Australia [J Antimicrob Chemother, 72, (2017) (1103-1108)] DOI:10.1093/jac/dkw422. Journal of Antimicrobial Chemotherapy, 72(4), 1270. Scopus39 WoS59 Europe PMC59 |
| 2016 | Lategan, M. J., Klare, W., Kidd, S., Hose, G. C., & Nevalainen, H. (2016). The unicellular fungal tool RhoTox for risk assessments in groundwater systems. Ecotoxicology and Environmental Safety, 132, 18-25. Scopus9 WoS8 Europe PMC5 |
| 2016 | McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia. BMC Infectious Diseases, 16(1), 1-7. Scopus32 WoS25 Europe PMC20 |
| 2016 | Morton, C. O., White, P. L., Barnes, R. A., Klingspor, L., Cuenca-Estrella, M., Lagrou, K., . . . Loeffler, J. (2016). Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus ?. Medical Mycology, 55(4), myw093. Scopus44 WoS42 Europe PMC31 |
| 2016 | Morris, A. J., Arthur, I. H., Kidd, S. E., Halliday, C. L., Meyer, W., Robson, J. M., . . . Haremza, E. (2016). Mycological testing of clinical samples in Australasian pathology laboratories: wide diversity and room for improvement. Pathology, 48(6), 531-534. Scopus6 WoS6 Europe PMC5 |
| 2016 | Kennedy, K. J., Daveson, K., Slavin, M. A., van Hal, S. J., Sorrell, T. C., Lee, A., . . . Chen, S. C. A. (2016). Mucormycosis in Australia: Contemporary epidemiology and outcomes. Clinical Microbiology and Infection, 22(9), 775-781. Scopus96 WoS82 Europe PMC82 |
| 2016 | Espinel-Ingroff, A., Colombo, A., Cordoba, S., Dufresne, P., Fuller, J., Ghannoum, M., . . . Turnidge, J. (2016). International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrobial Agents and Chemotherapy, 60(2), 1079-1084. Scopus145 WoS135 Europe PMC112 |
| 2016 | Halliday, C., Chen, S., Kidd, S., van Hal, S., Chapman, B., Heath, C., . . . Slavin, M. (2016). Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. International Journal of Antimicrobial Agents, 48(4), 453-458. Scopus29 WoS29 Europe PMC22 |
| 2015 | Slavin, M., van Hal, S., Sorrell, T., Lee, A., Marriott, D., Daveson, K., . . . Chambers, S. (2015). Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clinical Microbiology and Infection, 21(5), 490.e1-490.e10. Scopus166 WoS128 Europe PMC117 |
| 2015 | Halliday, C. L., Kidd, S. E., Sorrell, T. C., & Chen, S. C. A. (2015). Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?. Pathology, 47(3), 257-269. Scopus42 WoS33 Europe PMC30 |
| 2015 | van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., . . . Verweij, P. E. (2015). Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerging Infectious Diseases, 21(6), 1041-1044. Scopus349 WoS322 Europe PMC280 |
| 2015 | Espinel-Ingroff, A., & Kidd, S. E. (2015). Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infection and Drug Resistance, 8, 89-97. Scopus48 WoS43 Europe PMC36 |
| 2015 | Talbot, J. J., Kidd, S. E., Martin, P., Beatty, J. A., & Barrs, V. R. (2015). Azole resistance in canine and feline isolates of Aspergillus fumigatus. Comparative Immunology Microbiology and Infectious Diseases, 42, 37-41. Scopus21 WoS13 Europe PMC10 |
| 2015 | Kidd, S. E., Goeman, E., Meis, J. F., Slavin, M. A., & Verweij, P. E. (2015). Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses, 58(6), 350-355. Scopus96 WoS86 Europe PMC77 |
| 2015 | Gardiner, B. J., Simpson, I., Khuu, M. H., Kidd, S. E., Lo, C. H., & Jenkin, G. A. (2015). An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae. Medical Mycology Case Reports, 7, 8-11. Scopus6 WoS5 Europe PMC6 |
| 2015 | Espinel-Ingroff, A., Chakrabarti, A., Chowdhary, A., Cordoba, S., Dannaoui, E., Dufresne, P., . . . Turnidge, J. (2015). Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrobial Agents and Chemotherapy, 59(3), 1745-1750. Scopus111 WoS103 Europe PMC94 |
| 2015 | Espinel-Ingroff, A., Alvarez-Fernandez, M., Cantón, E., Carver, P., Chen, S., Eschenauer, G., . . . Turnidge, J. (2015). Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrobial Agents and Chemotherapy, 59(11), 6725-6732. Scopus61 WoS58 Europe PMC54 |
| 2015 | Brischetto, A., Kidd, S., & Baird, R. (2015). Case report: First reported Australian case of Cladophilophora arxii: Features consistent with possible primary pulmonary chromoblastomycosis. American Journal of Tropical Medicine and Hygiene, 92(4), 791-793. Scopus7 WoS8 Europe PMC7 |
| 2015 | Khoury, S., Kidd, S., & Warren, L. (2015). Neonatal tinea corporis due to a novel strain of Trichophyton rubrum. Australasian Journal of Dermatology, 56(4), 311-312. Scopus5 WoS4 Europe PMC5 |
| 2015 | Kidd, S., Halliday, C., & Ellis, D. (2015). The role of clinical mycology reference laboratories. Microbiology Australia, 36(2), 64-66. |
| 2014 | Subedi, S., Kidd, S. E., Baird, R. W., Coatsworth, N., & Ralph, A. P. (2014). Case Report: Sporotrichosis from the northern territory of Australia. American Journal of Tropical Medicine and Hygiene, 91(6), 1263-1268. Scopus7 WoS9 Europe PMC6 |
| 2014 | Macesic, N., Fleming, S., Kidd, S., Madigan, V., Chean, R., Ritchie, D., & Slavin, M. (2014). Protothecosis in hematopoietic stem cell transplantation: Case report and review of previous cases. Transplant Infectious Disease, 16(3), 490-495. Scopus20 WoS16 Europe PMC14 |
| 2014 | Talbot, J. J., Johnson, L. R., Martin, P., Beatty, J. A., Sutton, D. A., Billen, F., . . . Barrs, V. R. (2014). What causes canine sino-nasal aspergillosis? A molecular approach to species identification. Veterinary Journal, 200(1), 17-21. Scopus26 WoS21 Europe PMC17 |
| 2014 | Coad, B., Kidd, S., Ellis, D., & Griesser, H. (2014). Biomaterials surfaces capable of resisting fungal attachment and biofilm formation. Biotechnology Advances, 32(2), 296-307. Scopus69 WoS63 Europe PMC42 |
| 2013 | Chen, S. C. A., Korman, T. M., Slavin, M. A., Marriott, D., Byth, K., Bak, N., . . . Sorrell, T. C. (2013). Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clinical Infectious Diseases, 57(4), 543-551. Scopus106 WoS94 Europe PMC88 |
| 2013 | Barrs, V., van Doorn, T., Houbraken, J., Kidd, S., Martin, P., Pinheiro, M., . . . Samson, R. (2013). Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS ONE, 8(6), e64871-1-e64871-11. Scopus102 WoS88 Europe PMC75 |
| 2013 | Holmes, N. E., Trevillyan, J. M., Kidd, S. E., & Leong, T. Y. M. (2013). Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma. Medical Mycology Case Reports, 2(1), 98-102. Scopus15 WoS12 Europe PMC12 |
| 2012 | Bartlett, K. H., Cheng, P. Y., Duncan, C., Galanis, E., Hoang, L., Kidd, S., . . . Kronstad, J. (2012). A Decade of Experience: Cryptococcus gattii in British Columbia. Mycopathologia, 173(5-6), 311-319. Scopus63 WoS56 Europe PMC51 |
| 2012 | Chen, S. C. A., Slavin, M. A., Heath, C. H., Geoffrey Playford, E., Byth, K., Marriott, D., . . . Sorrell, T. C. (2012). Clinical manifestations of cryptococcus gattii infection: Determinants of neurological sequelae and death. Clinical Infectious Diseases, 55(6), 789-798. Scopus178 WoS158 Europe PMC142 |
| 2012 | Espinel-Ingroff, A., Aller, A., Canton, E., Castanon-Olivares, L., Chowdhary, A., Cordoba, S., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole. Antimicrobial Agents and Chemotherapy, 56(11), 5898-5906. Scopus227 WoS213 Europe PMC190 |
| 2012 | Espinel-Ingroff, A., Chowdhary, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Hagen, F., . . . Turnidge, J. (2012). Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine. Antimicrobial Agents and Chemotherapy, 56(6), 3107-3113. Scopus135 WoS125 Europe PMC115 |
| 2011 | D'Souza, C. A., Kronstad, J. W., Taylor, G., Warren, R., Yuen, M., Hu, G., . . . Cuomoe, C. A. (2011). Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. Mbio, 2(1), 11 pages. Scopus178 WoS164 Europe PMC160 |
| 2010 | Galanis, E., Macdougall, L., Kidd, S., Morshed, M., & British Columbia Cryptococcus gattii Working Group. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.. Emerging infectious diseases, 16(2), 251-257. Europe PMC199 |
| 2010 | Galanis, E., & MacDougall, L. (2010). Epidemiology of <i>Cryptococcus gattii</i>, British Columbia, Canada, 1999-2007. EMERGING INFECTIOUS DISEASES, 16(2), 251-257. WoS221 |
| 2009 | Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191. WoS205 Europe PMC176 |
| 2009 | Datta, K., Bartlett, K. H., Baer, R., Byrnes, E., Galanis, E., Heitman, J., . . . Marr, K. A. (2009). Spread of Cryptococcus gattii into Pacific Northwest Region of the United States. EMERGING INFECTIOUS DISEASES, 15(8), 1185-1191. WoS205 Europe PMC176 |
| 2009 | Kidd, S. E., Ling, L. M., Meyer, W., Morrissey, C. O., Chen, S. C. A., & Slavin, M. A. (2009). Molecular epidemiology of invasive aspergillosis: Lessons learned from an outbreak investigation in an Australian hematology unit. Infection Control and Hospital Epidemiology, 30(12), 1223-1226. Scopus15 WoS12 Europe PMC10 |
| 2009 | Kidd, S. E., Nik Zulkepeli, N. A. A., Slavin, M. A., & Morrissey, C. O. (2009). Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications. Journal of Microbiological Methods, 78(2), 223-226. Scopus16 WoS13 Europe PMC12 |
| 2009 | Hurst, S. F., Kidd, S. E., Morrissey, C. O., Snelders, E., Melchers, W. J. G., Castelli, M. V., . . . Arunmozhi Balajee, S. (2009). Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus. Journal of Clinical Microbiology, 47(5), 1562-1564. Scopus14 WoS13 Europe PMC10 |
| 2008 | Bartlett, K. H., Kidd, S. E., & Kronstad, J. W. (2008). The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1), 58-65. Scopus94 Europe PMC79 |
| 2007 | Upton, A., Fraser, J. A., Kidd, S. E., Bretz, C., Bartlett, K. H., Heitman, J., & Marr, K. A. (2007). First contemporary case of human infection with Cryptococcus gattii in puget sound: Evidence for spread of the Vancouver Island outbreak. Journal of Clinical Microbiology, 45(9), 3086-3088. Scopus74 WoS65 Europe PMC61 |
| 2007 | Kidd, S. E., Bach, P. J., Hingston, A. O., Mak, S., Chow, Y., MacDougall, L., . . . Bartlett, K. H. (2007). Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerging Infectious Diseases, 13(1), 51-57. Scopus127 WoS109 Europe PMC93 |
| 2007 | MacDougall, L., Kidd, S. E., Galanis, E., Mak, S., Leslie, M. J., Cieslak, P. R., . . . Bartlett, K. H. (2007). Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerging Infectious Diseases, 13(1), 42-50. Scopus258 WoS212 Europe PMC182 |
| 2007 | Kidd, S. E., Chow, Y., Mak, S., Bach, P. J., Chen, H., Hingston, A. O., . . . Bartlett, K. H. (2007). Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Applied and Environmental Microbiology, 73(5), 1433-1443. Scopus201 WoS185 Europe PMC151 |
| 2006 | Filion, T., Kidd, S., & Aguirre, K. (2006). Isolation of Cryptococcus laurentii from Canada Goose guano in rural upstate New York. Mycopathologia, 162(5), 363-368. Scopus16 WoS14 Europe PMC10 |
| 2005 | Kidd, S. E., Guo, H., Bartlett, K. H., Xu, J., & Kronstad, J. W. (2005). Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryotic Cell, 4(10), 1629-1638. Scopus102 WoS96 Europe PMC82 |
| 2004 | Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., . . . Meyer, W. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17258-17263. Scopus662 WoS602 Europe PMC536 |
| 2004 | Igreja, R. P., Dos Santos Lazéra, M., Wanke, B., Gutierrez Galhardo, M. C., Kidd, S. E., & Meyer, W. (2004). Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Medical Mycology, 42(3), 229-238. Scopus51 WoS48 Europe PMC44 |
| 2004 | Katsu, M., Kidd, S., Ando, A., Moretti-Branchini, M. L., Mikami, Y., Nishimura, K., & Meyer, W. (2004). The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research, 4(4-5), 377-388. Scopus105 WoS100 Europe PMC81 |
| 2003 | Kidd, S. E., Sorrell, T. C., & Meyer, W. (2003). Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Medical Mycology, 41(2), 171-176. Scopus43 WoS39 Europe PMC28 |
| Year | Citation |
|---|---|
| 2026 | Kidd, S., Halliday, C., & Ellis, D. (2026). Descriptions of Medical Fungi. CABI. DOI |
| 2016 | Kidd, S., Halliday, C., Alexiou, H., & Ellis, D. (2016). Descriptions of Medical Fungi Third Edition. |
| Year | Citation |
|---|---|
| 2022 | Hilmarsdóttir, I., Kidd, S., & Lau, A. (2022). Chapter 87: Mycology. In N. Rifai (Ed.), Tietz Textbook of Laboratory Medicine - E-Book (7th ed.). Elsevier Health Sciences. |
| 2022 | Hilmarsdóttir, I., Kidd, S. E., & Lau, A. F. (2022). Mycology. In Tietz Textbook of Laboratory Medicine Seventh Edition (pp. 1204-1204.e171). DOI |
| 2019 | Kidd, S. E. (2019). Cryptococcosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association. DOI |
| 2019 | Kidd, S. E., & Arthur, I. (2019). Sporotrichosis. In B. W. Wilcke Jr, & D. L. Heymann (Eds.), Control of Communicable Diseases. American Public Health Association. DOI |
| 2018 | Halliday, C. L., & Kidd, S. E. (2018). Cryptococcus species. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 81-82). Oxford University Press. DOI |
| 2018 | Kidd, S. E., & Halliday, C. H. (2018). Dematiaceous fungi. In C. C. Kibbler, R. Barton, N. A. R. Gow, S. Howell, D. M. MacCallum, & R. J. Manuel (Eds.), Oxford Textbook of Medical Mycology (pp. 88-92). UK: Oxford University Press. DOI |
| 2014 | Bartlett, K., Byrnes, E., Duncan, C., Fyfe, M., Galanis, E., Heitman, J., . . . Kronstad, J. (2014). The Emergence of Cryptococcus gattii Infections on Vancouver Island and Expansion in the Pacific Northwest. In J. Heitman, T. R. Kozel, K. J. KwonChung, J. R. Perfect, & A. Casadevall (Eds.), Cryptococcus from Human Pathogen to Model Yeast (pp. 313-325). AMER SOC MICROBIOLOGY. DOI Scopus7 WoS7 |
| Year | Citation |
|---|---|
| 2021 | Crawford, L., Turra, M., Kidd, S., & Weldhagen, G. (2021). Candida auris PCR for high throughput infection control screening. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia. |
| 2021 | Crawford, L., & Kidd, S. (2021). Simple detection and differentiation of Candida auris on CHROMagar Candida Plus agar. In Australasian Society for Infectious Diseases Annual Scientific Meeting. Australia. |
| 2019 | Crawford, L. C., Tam, P., Kidd, S., & Nelson, R. (2019). Scopulariopsis gracilis septic arthritis in an immunocompromised host. In Mycology Masterclass. Kingscliff, NSW, Australia. |
| 2016 | McGuinness, S., Boyd, R., Kidd, S., McLeod, C., Krause, V., & Ralph, A. (2016). Epidemiological Investigation Of An Outbreak Of Sporotrichosis. In INTERNAL MEDICINE JOURNAL Vol. 46 (pp. 12-13). WILEY-BLACKWELL. DOI |
| 2014 | Viiret, E., Birader, M., Holmes, M., Kidd, S., & Holmes-Liew, C. (2014). UTILITY OF BRONCHOALVEOLAR LAVAGE GALACTOMANNAN IN DIAGNOSIS OF ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. In RESPIROLOGY Vol. 19 (pp. 127). WILEY-BLACKWELL. |
| 2012 | Chen, S., Slavin, M., Heath, C., Playford, E. G., Byth, K., Marriott, D., . . . Sorrell, T. (2012). <i>Cryptococcus gattii</i> infection: Long term morbidity and determinants of neurological sequelae and death. In MYCOSES Vol. 55 (pp. 78). WILEY-BLACKWELL. |
| 2007 | Galanis, E., MacDougall, L., Li, M., Kidd, S., Lee, M., & Morshed, M. (2007). Clinical and epidemiological aspects of locally-acquired <i>Cryptococcus gattii</i> human infections, an emerging fungal pathogen in British Columbia, Canada. In INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS Vol. 29 (pp. S34-S35). Munich, GERMANY: ELSEVIER SCIENCE BV. DOI |
| 2004 | Bartlett, K. H., MacDougall, L., Mak, S., Duncan, C., Kidd, S., & Fyfe, M. (2004). Cryptococcus gattii, a tropical pathogen emerging in a temperate climate zone. In 16th Conference on Biometeorology and Aerobiology (pp. 39-43). Scopus1 |
| Year | Citation |
|---|---|
| 2019 | Nelson, R., Crawford, L., Kidd, S., & Tam, P. C. K. (2019). Scopulariopsis gracilis septic arthritis. Poster session presented at the meeting of Mycology Master Class. |
| 2017 | Espinel-Ingroff, A., Abreu, D. P. B., Almeida-Paes, D., Brilhante, R. S. N., Chakrabarti, A., Chowdhary, A., . . . Turnidge, J. (2017). International evaluation of CLSI MIC/MEC distributions for definition of epidemiological cutoff values (ECVs) for species of Sporothrix identified by molecular methods. Poster session presented at the meeting of MYCOSES. WILEY. |
| 2013 | Birader, M. I., Kidd, S., & Holmes-Liew, C. -L. (2013). OPTIMAL UTILITY OF BAL FLUID GALACTOMANNAN IN DIAGNOSING INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS. Poster session presented at the meeting of RESPIROLOGY. WILEY-BLACKWELL. |
| 2013 | Birader, M. I., Holmes, M. D., Kidd, S., & Holmes-Liew, C. L. (2013). Utility of bronchoalveolar lavage galactomannan in diagnosis of Aspergillosis in lung transplant recipients. Poster session presented at the meeting of Abstracts from the 33rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, as published in Journal of Heart and Lung Transplantation. Montreal, Canada: Elsevier. DOI |
| Year | Citation |
|---|---|
| 2003 | Kidd, S. (2003). Molecular epidemiology and characterisation of genetic structure to assess speciation within the Cryptococcus neoformans complex. (PhD Thesis, University of Sydney). |
| Year | Citation |
|---|---|
| 2014 | Kidd, S. E., & ellis, D. (2014). Australian Antifungal Susceptibility Trends in Yeasts: 2000-2013.. Australian Society of Antimicrobials. |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2019 - 2019 | Member | ASM Scientific Program Committee, Adelaide, 2019 | Australian Society for Microbiology | Australia |
| 2012 - 2017 | Co-Chair | Organising Committee, ISHAM Conference, Melbourne May 4-8 2015 | ANZMIG | Australia |
| 2011 - ongoing | Advisory Board Member | RCPA QAP Microbiology | Royal College of Pathologists Quality Assurance Program | Australia |
| 2011 - ongoing | Secretary | Australia New Zealand Mycoses Interest Group (ANZMIG) | Australasian Society for Infectious Diseases | Australia |
| 2011 - 2013 | Member | ASM Conference Local Organising Committee, Adelaide 2013 | ASM | Australia |
| 2011 - ongoing | Chair | Mycology Masterclass (Biennial event) | ANZMIG | Australia |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2023 - ongoing | Member | American Society for Microbiology | United States |
| 2018 - ongoing | Member | Australian Society for Antimicrobials | Australia |
| 2012 - ongoing | Member | International Society for Human and Animal Mycology | - |
| 2011 - ongoing | Member | Australasian Society for Infectious Diseases (ASID) | Australia |
| 2001 - ongoing | Member | Australian Society for Microbiology | Australia |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2018 - ongoing | ASA EUCAST National AST Committee (AusNAC) | - | Scientific research | Australia |
| 2017 - ongoing | National Association of Testing Authorities | - | Health services and related | Australia |
| 2016 - ongoing | International Accreditation New Zealand (IANZ) | - | Health services and related | New Zealand |
| 2015 - ongoing | Merck Sharp & Dohme | - | Health services and related | Australia |
| 2014 - ongoing | Mayne Pharma | - | Health services and related | Australia |
| 2011 - ongoing | Pfizer Anti-infectives | - | Health services and related | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2024 - 2026 | Board Member | ASM Case Reports | American Society of Microbiology | United States |
| 2018 - 2021 | Editor | Journal of Medical Microbiology | Microbiology Society | United Kingdom |
